Tumor microenvironment on the move and the Aselli connection-Reference-Cited by-同舟云学术

Tumor microenvironment on the move and the Aselli connection

Published:2016-06-28 Issue:434 Volume:9 Page:
ISSN:1945-0877
Container-title:Science Signaling
language:en
Short-container-title:Sci. Signal.

Author:

Rodvold Jeffrey J.¹,Zanetti Maurizio¹

Affiliation:

1. The Laboratory of Immunology, Department of Medicine and Moores Cancer Center, University of California, San Diego, 9500 Gilman Drive, La Jolla, San Diego, CA 92093-0815, USA.

Abstract

The innate immune response mediates signals that remodel the tumor microenvironment and promotes lymphangiogenesis.

Funder

NIH

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference11 articles.

1. Lymphangiogenesis and lymphatic vessel remodelling in cancer

2. Lipocalin 2 from macrophages stimulated by tumor cell–derived sphingosine 1-phosphate promotes lymphangiogenesis and tumor metastasis

3. Sphingosine-1-Phosphate Produced by Sphingosine Kinase 1 Promotes Breast Cancer Progression by Stimulating Angiogenesis and Lymphangiogenesis

4. Lipocalin 2 in cancer: When good immunity goes bad

5. Lipocalin 2 promotes breast cancer progression

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global cluster analysis and network visualization in cancer-associated fibroblast: insights from Web of Science database from 1999 to 2021;European Journal of Medical Research;2023-11-29

2. Tumor-associated fibroblasts derived exosomes induce the proliferation and cisplatin resistance in esophageal squamous cell carcinoma cells through RIG-I/IFN-β signaling;Bioengineered;2022-05-02

3. The Unfolded Protein Response at the Tumor-Immune Interface;Frontiers in Immunology;2022-02-14

4. Myeloid-Derived Suppressor Cells Recruited by Chemokine (C-C Motif) Ligand 3 Promote the Progression of Breast Cancer via Phosphoinositide 3-Kinase-Protein Kinase B-Mammalian Target of Rapamycin Signaling;Journal of Breast Cancer;2020

5. RU486 Metabolite Inhibits CCN1/Cyr61 Secretion by MDA-MB-231-Endothelial Adhesion;Frontiers in Pharmacology;2019-11-20